Clinical Trial Update: Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue [Phase 3]

View source ↗

Summary

A Phase 3 trial update reports lot-to-lot consistency for the tetravalent dengue vaccine TDV in non-endemic settings; results posted in 2020. The study focuses …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• TDV (tetravalent dengue vaccine)

Snippet

Sponsor: Takeda | Conditions: Dengue Fever | Phase 3 | Status: COMPLETED | Results posted: 2020-10-20